Chugai Pharmaceutical Co. Ltd. - Cost of Goods Sold Including Depreciation and Amortization

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.

The item "Cost-of-Goods-Sold-Including-Depreciation-and-Amortization" stands at 354.41 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 03/31/2024.

Chugai Pharmaceutical Co. Ltd.'s second quarter result of 88.07 Billion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 0.28 percent compared to it's first quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s second quarter result of 88.07 Billion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 0.15 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s second quarter result of 354.41 Billion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 0.04 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.01 percent compared to the value the year prior.
The 1 year change in percent is 7.01.
The 3 year change in percent is -13.25.
The 5 year change in percent is 31.34.
The 10 year change in percent is 52.31.

The Serie's long term average value is 276.23 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 28.30 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 06/30/2025, is +125.02%.
The Serie's change in percent from it's maximum value, on 09/30/2023, to it's latest available value, on 06/30/2025, is -33.65%.